Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 13
1.2 List of Figures 21
2 Introduction 24
2.1 What Is This Report
About? 24
3 Definitions of Markets Covered in the Report 25
3.1
Cardiovascular Devices 25
3.2 Cardiac Rhythm Management 25
3.2.1
Pacemakers 25
3.2.2 Implantable Cardioverter Defibrillator (ICD) 25
3.2.3 Cardiovascular Pacing and ICD Leads 26
3.2.4 Cardiac
Resynchronization Therapy 26
3.3 Cardiovascular monitoring and diagnostic
devices 26
3.3.1 ECG Monitoring Equipment 26
3.3.2 ECG Stress Testing
Systems 26
3.3.3 Holter Monitoring Systems 26
3.3.4 Event Monitoring
Systems 26
3.4 Cardiovascular prosthetic device 27
3.4.1 Prosthetic
heart valves 27
3.4.2 Cardiac Valve Repair 27
3.4.3 Cardiac assist
devices (Ventricular Assist Device (VAD)) 27
3.5 Cardiovascular Surgery
28
3.5.1 Beating Heart Systems 28
3.5.2 Perfusion Systems 28
3.5.3
Cardiac Ablation Devices 28
3.5.4 Cardiopulmonary Bypass Equipment 28
3.5.5 Perfusion Disposables 28
3.6 Electrophysiology 29
3.6.1
Electrophysiology diagnostic catheter 29
3.6.2 Electrophysiology ablation
catheter 29
3.6.3 Electrophysiology lab systems 29
3.7 Interventional
cardiology 29
3.7.1 Coronary Stents 29
3.7.2 Cardiac Catheters 29
3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
30
3.7.4 Coronary Guidewire 30
3.7.5 Arteriotomy Closure Devices
30
3.8 Peripheral vascular devices 31
3.8.1 Peripheral Vascular Stents
31
3.8.2 Inferior Vena Cava Filter 31
3.8.3 PTA Balloon 31
3.8.4
Aortic Stent Graft 31
3.8.5 Embolic Protection Device 31
3.8.6
Synthetic Surgical Grafts 31
3.8.7 Peripheral Guidewire 31
4
Healthcare Sector Review 32
4.1 Healthcare Expenditure 32
4.2
Healthcare Infrastructure 34
4.2.1 Healthcare Personnel Data 36
4.3
United States Healthcare Trade Statistics 38
5 Regulation System 39
5.1 Regulation System 39
5.2 Medical Equipment Approval Process 39
5.2.1 Pre-market Approval Process 40
5.2.2 Intended use and Indications
for use 40
5.2.3 Predicate Device 41
5.2.4 Safe and Effective 41
5.2.5 Other Category Devices 43
5.2.6 Post-Market Approval Process 44
5.2.7 Compliance and Enforcement 44
5.2.8 Registration Fee 45
5.2.9
Approval Time 45
6 Pricing and Reimbursement 46
6.1 Government
Policies 46
6.2 Private Insurance 47
6.3 Diagnosis Related Groups
(DRG) 48
7 Distribution Structure 49
7.1 Distribution Structure 49
8 Cardiovascular Devices In United States 50
8.1 Cardiovascular Devices,
Cross Country Comparison, Revenue ($ mn), 2000-2015 50
8.2 Cardiovascular
Devices, United States, Overall Revenue ($ mn), 2000-2015 51
8.3
Cardiovascular Devices, United States, Category Volume (Units), 2000-2015
57
8.4 Cardiovascular Devices, United States, Company Share (2007-2008)
59
9 Cardiac Rhythm Management In United States 60
9.1 Cardiac Rhythm
Management Overall Revenue (2000-2015) 60
9.1.1 Cardiac Resynchronisation
Therapy Revenue (2000-2015) 62
9.1.2 Implantable Cardioverter
Defibrillator Revenue (2000-2015) 64
9.1.3 Pacemaker Revenue (2000-2015)
66
9.2 Cardiac Rhythm Management Overall Volume (2000-2015) 68
9.2.1
Cardiac Resynchronisation Therapy Volume (2000-2015) 70
9.2.2 Implantable
Cardioverter Defibrillator Volume (2000-2015) 72
9.2.3 Pacemaker Volume
(2000-2015) 74
9.3 Cardiac Rhythm Management Average Price (2000-2015)
76
9.4 Cardiac Rhythm Management Distribution Share (2007-2008) 77
9.5
Cardiac Rhythm Management, United States, Company Share (2007-2008) 78
10
Cardiovascular Monitoring and Diagnostic Devices In United States 79
10.1
Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
79
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume
(2000-2015) 83
10.3 Cardiovascular Monitoring and Diagnostic Devices
Average Price (2000-2015) 85
10.4 Cardiovascular Monitoring and Diagnostic
Devices Distribution Share (2007-2008) 86
10.5 Cardiovascular Monitoring
and Diagnostic Devices, United States, Company Share (2007-2008) 87
11
Cardiovascular Prosthetic Devices In United States 88
11.1 Cardiovascular
Prosthetic Devices Overall Revenue (2000-2015) 88
11.1.1 Cardiac Assist
Devices Revenue (2000-2015) 90
11.1.2 Prosthetic Heart Valve Revenue
(2000-2015) 92
11.2 Cardiovascular Prosthetic Devices Overall Volume
(2000-2015) 94
11.2.1 Cardiac Assist Devices Volume (2000-2015) 96
11.2.2 Prosthetic Heart Valve Volume (2000-2015) 98
11.3 Cardiovascular
Prosthetic Devices Average Price (2000-2015) 100
11.4 Cardiovascular
Prosthetic Devices Distribution Share (2007-2008) 101
11.5 Cardiovascular
Prosthetic Devices, United States, Company Share (2007-2008) 102
12
Cardiovascular Surgery In United States 104
12.1 Cardiovascular Surgery
Overall Revenue (2000-2015) 104
12.1.1 Perfusion Disposables Revenue
(2000-2015) 107
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
109
12.2.1 Perfusion Disposables Volume (2000-2015) 110
12.3
Cardiovascular Surgery Average Price (2000-2015) 112
12.4 Cardiovascular
Surgery Distribution Share (2007-2008) 113
12.5 Cardiovascular Surgery,
United States, Company Share (2007-2008) 114
13 Electrophysiology In
United States 115
13.1 Electrophysiology Overall Revenue (2000-2015)
115
13.2 Electrophysiology Overall Volume (2000-2015) 117
13.3
Electrophysiology Average Price (2000-2015) 118
13.4 Electrophysiology
Distribution Share (2007-2008) 119
13.5 Electrophysiology, United States,
Company Share (2007-2008) 120
14 Interventional Cardiology In United
States 121
14.1 Interventional Cardiology Overall Revenue (2000-2015)
121
14.1.1 Cardiac Catheter Revenue (2000-2015) 125
14.1.2 Coronary
Stent Revenue (2000-2015) 127
14.1.3 PTCA Balloon Revenue (2000-2015)
129
14.2 Interventional Cardiology Overall Volume (2000-2015) 131
14.2.1 Cardiac Catheter Volume (2000-2015) 135
14.2.2 Coronary Stent
Volume (2000-2015) 137
14.2.3 PTCA Balloon Volume (2000-2015) 139
14.3
Interventional Cardiology Average Price (2000-2015) 141
14.4
Interventional Cardiology Distribution Share (2007-2008) 143
14.5
Interventional Cardiology, United States, Company Share (2007-2008) 144
15
Peripheral Vascular Devices In United States 145
15.1 Peripheral Vascular
Devices Overall Revenue (2000-2015) 145
15.2 Peripheral Vascular Devices
Overall Volume (2000-2015) 149
15.3 Peripheral Vascular Devices Average
Price (2000-2015) 153
15.4 Peripheral Vascular Devices Distribution Share
(2007-2008) 154
15.5 Peripheral Vascular Devices, United States, Company
Share (2007-2008) 155
16 Overview of Key Companies in Cardiovascular
Devices Market in United States 156
16.1 Boston Scientific Corporation
Company Profile 156
16.1.1 Company Overview 156
16.1.2 Value Chain
Analysis 156
16.1.3 Boston Scientific Corporation Pipeline Products
159
16.2 Medtronic, Inc. Company Profile 165
16.2.1 Company Overview
165
16.2.2 Value Chain Analysis 166
16.2.3 Medtronic, Inc. Pipeline
Products 167
16.3 Cordis Corporation Company Profile 175
16.3.1
Company Overview 175
16.3.2 Cordis Corporation Pipeline Products 175
16.4 St. Jude Medical Inc. Company Profile 178
16.4.1 Company Overview
178
16.4.2 Value Chain Analysis 179
16.4.3 St. Jude Medical Inc.
Pipeline Products 182
16.5 Abbott Laboratories Company Profile 185
16.5.1 Company Overview 185
16.5.2 Value Chain Analysis 186
16.5.3
Abbott Laboratories Pipeline Products 188
16.6 Terumo Corporation Company
Profile 190
16.6.1 Company Overview 190
16.6.2 Value Chain Analysis
190
16.6.3 Terumo Corporation Pipeline Products 192
16.7 Abbott
Vascular Company Profile 194
16.7.1 Company Overview 194
16.7.2 Abbott
Vascular Pipeline Products 194
16.8 ABIOMED, Inc. Company Profile 197
16.8.1 Company Overview 197
16.8.2 Value Chain Analysis 197
16.8.3
ABIOMED, Inc. Pipeline Products 199
16.9 AGA Medical Corporation Company
Profile 201
16.9.1 Company Overview 201
16.9.2 AGA Medical Corporation
Pipeline Products 201
16.10 Angel Medical Systems, Inc. Company Profile
203
16.10.1 Company Overview 203
16.10.2 Angel Medical Systems, Inc.
Pipeline Products 203
16.11 Arrow International, Inc. Company Profile
204
16.11.1 Company Overview 204
16.11.2 Value Chain Analysis 205
16.11.3 Arrow International, Inc. Pipeline Products 207
16.12 Ash Access
Technology, Inc. Company Profile 208
16.12.1 Company Overview 208
16.12.2 Ash Access Technology, Inc. Pipeline Products 208
16.13 AtriCure,
Inc. Company Profile 209
16.13.1 Company Overview 209
16.13.2
AtriCure, Inc. Pipeline Products 209
16.14 Atritech, Inc. Company Profile
211
16.14.1 Company Overview 211
16.14.2 Atritech, Inc. Pipeline
Products 211
16.15 Atrium Medical Corporation Company Profile 213
16.15.1 Company Overview 213
16.15.2 Atrium Medical Corporation Pipeline
Products 213
16.16 ATS Medical, Inc. Company Profile 215
16.16.1
Company Overview 215
16.16.2 ATS Medical, Inc. Pipeline Products 215
16.17 BioCardia, Inc. Company Profile 217
16.17.1 Company Overview 217
16.17.2 BioCardia, Inc. Pipeline Products 217
16.18 Bioheart, Inc. Company
Profile 218
16.18.1 Company Overview 218
16.18.2 Bioheart, Inc.
Pipeline Products 218
16.19 Biosite Incorporated Company Profile 220
16.19.1 Company Overview 220
16.19.2 Value Chain Analysis 220
16.19.3
Biosite Incorporated Pipeline Products 223
16.20 Bolton Medical, Inc.
Company Profile 225
16.20.1 Company Overview 225
16.20.2 Bolton
Medical, Inc. Pipeline Products 225
16.21 C.R. Bard, Inc. Company Profile
226
16.21.1 Company Overview 226
16.21.2 Value Chain Analysis 226
16.21.3 C.R. Bard, Inc. Pipeline Products 228
16.22 Cardiac Dimensions,
Inc. Company Profile 231
16.22.1 Company Overview 231
16.22.2 Cardiac
Dimensions, Inc. Pipeline Products 231
16.23 Cardiac Science Corporation
Company Profile 233
16.23.1 Company Overview 233
16.23.2 Value Chain
Analysis 234
16.24 Cardica, Inc. Company Profile 236
16.24.1 Company
Overview 236
16.25 Cardima, Inc. Company Profile 237
16.25.1 Company
Overview 237
16.25.2 Cardima, Inc. Pipeline Products 237
16.26
Cardiovascular Systems, Inc. Company Profile 239
16.26.1 Company Overview
239
16.26.2 Cardiovascular Systems, Inc. Pipeline Products 239
16.27
CONMED Corporation Company Profile 240
16.27.1 Company Overview 240
16.27.2 Value Chain Analysis 240
16.28 Cook Medical Company Profile
243
16.28.1 Company Overview 243
16.28.2 Cook Medical Pipeline
Products 243
16.29 Datascope Corporation Company Profile 246
16.29.1
Company Overview 246
16.29.2 Value Chain Analysis 246
16.29.3
Datascope Corporation Pipeline Products 249
16.30 Edwards Lifesciences
Corporation Company Profile 250
16.30.1 Company Overview 250
16.30.2
Value Chain Analysis 250
16.30.3 Edwards Lifesciences Corporation Pipeline
Products 253
16.31 ev3 Inc. Company Profile 256
16.31.1 Company
Overview 256
16.31.2 Value Chain Analysis 257
16.31.3 ev3 Inc.
Pipeline Products 259
16.32 Kensey Nash Corporation Company Profile
261
16.32.1 Company Overview 261
16.32.2 Kensey Nash Corporation
Pipeline Products 261
16.33 Philips Healthcare Company Profile 263
16.33.1 Company Overview 263
16.33.2 Value Chain Analysis 264
16.33.3
Philips Healthcare Pipeline Products 266
16.34 Thoratec Corporation
Company Profile 268
16.34.1 Company Overview 268
16.34.2 Value Chain
Analysis 269
16.34.3 Thoratec Corporation Pipeline Products 271
16.35
W. L. Gore & Associates, Inc. Company Profile 273
16.35.1 Company Overview
273
16.35.2 W. L. Gore & Associates, Inc. Pipeline Products 273
16.36
Welch Allyn Inc. Company Profile 275
16.36.1 Company Overview 275
17
Financial Deals Landscape 276
17.1 Merger 276
17.1.1 Iowa Heart Center
To Merge With Mercy Medical Center 276
17.2 Acquisition 277
17.2.1
Covidien To Acquire VNUS Medical Technologies 277
17.2.2 Medtronic
Acquires CoreValve From Sofinnova Partners, Apax Partners, HealthCap And
Maverick Capital 278
17.2.3 CardioNet To Acquire Biotel 280
17.3
Venture Financing 281
17.3.1 Global Cardiovascular Innovation Center
Invests $0.5 Million In Navis Medical And EXCMR 281
17.3.2 CardiAQ Valve
Technologies Secures Additional $0.11 Million In Seed Funding 282
17.3.3
Pathway Medical Technologies Secures $42.5 Million In Series D Financing
283
17.3.4 iRhythm Technologies Secures An Additional $6.53 Million In
First Round Of Financing 285
17.3.5 Control Medical Technology Secures
Series A Round Of Financing 286
17.3.6 Revascular Therapeutics Raises $3
Million In Second Tranche Of Series B Financing 287
17.3.7 Sadra Medical
Secures $30 Million In Series C Financing 288
17.3.8 SquareOne Secures
$3.4 Million In Bridge Financing 290
17.4 Equity Offerings 291
17.4.1
Endologix Files For Public Offering Of $50 Million 291
17.4.2 ATS Medical
Files Registration Statement For Public Offering Of $100 Million 292
17.4.3 Hansen Medical Completes Public Offering Of $37.9 Million 293
17.5
Partnerships 294
17.5.1 AorTech International Enters Into Licensing
Agreement For Elast-Eon 294
17.5.2 Svelte Medical Systems Enters Into
Licensing Agreement With Cordis 295
17.5.3 Welch Allyn Enters Into An
Agreement With Schiller 296
18 Recent Developments 297
18.1 Strategy
And Business Planning 297
18.1.1 May 21, 2009: Johnson & Johnson Acquires
Cougar For $1b 297
18.1.2 May 19, 2009: Elixir Signs Option Agreement with
Novartis 297
18.1.3 May 18, 2009: MEI And GE Healthcare Sign Strategic
Agreement 297
18.1.4 May 18, 2009: Stentys Launches US Operations In
Princeton, New Jersey 298
18.1.5 May 15, 2009: Xtent Board Approves Plan
Of Liquidation 298
18.1.6 May 14, 2009: Royal Philips And Hansen Medical
To Integrate X-ray Imaging And Robotic Catheter 299
18.1.7 May 11, 2009:
Medtronic Announces San Antonio As Home Of New Diabetes Facility 299
18.1.8 Apr 13, 2009: St. Jude Medical Announces Expansion Of Its Liberty
Operations 300
18.1.9 Apr 08, 2009: Philips To Make India Hub For
Manufacturing Of Medical Equipment 301
18.2 Legal and Regulatory 302
18.2.1 May 19, 2009: L&K Announces Investigation Against VNUS 302
18.2.2
May 08, 2009: Medtronic And Johnson & Johnson Reach Agreement On Royalty
Disputes 302
18.2.3 May 04, 2009: Attorney General Cox, Treasurer Kleine
Recover $24.5 Million For State Pension Fund 302
18.2.4 Apr 21, 2009: St.
Jude Medical Gets FDA Letter On Quality At Minnetonka Plant 303
18.2.5 Mar
31, 2009: Appeals Court Affirms J&J Stents Infringe Boston Scientific Patent,
Claims Against TAXUS Liberte Dismissed 303
18.3 Government and Public
Interest 304
18.3.1 May 28, 2009: FCC May Widen Spectrum For Wireless
Radio Devices 304
18.3.2 May 14, 2009: EHRA And HRS Release Expert
Consensus Statement On The Catheter Ablation of VT 304
18.3.3 May 13,
2009: HRS Releases Expert Consensus Statement On Lead Extraction In Patients
With Cardiovascular Implantable Electronic Devices 305
18.3.4 May 13,
2009: HRS Offers First Comprehensive Guidance On Lead Performance 306
18.3.5 May 07, 2009: FDA Plans National Registry To Monitor AF Ablation Safety
307
18.3.6 Apr 17, 2009: Draft Guidance For Industry And FDA Staff:
Investigational Device Exemption Guidance For Retinal Prostheses 307
18.3.7 Apr 07, 2009: Maryland Lawmakers Aims To Limit Liability For
Defibrillator Use 307
18.3.8 Mar 30, 2009: Cardiologists Worry About
Possible Payment Limits To Restrain Health Costs 308
18.4 Product
Approvals 309
18.4.1 May 19, 2009: Cardiva Medical Announces FDA Approval
For Catalyst III System 309
18.4.2 May 13, 2009: Rafael Medical
Technologies Receives FDA Clearance For Its SafeFlo Vena Cava Filter 309
18.4.3 May 12, 2009: US FDA Grants Clearance To ATS Medical' s Simulus
Adjustable Annuloplasty Band 310
18.4.4 May 08, 2009: Edwards
Lifesciences' Carpentier-Edwards PERIMOUNT Magna Ease Aortic Valve Receives
FDA Approval 310
18.4.5 May 06, 2009: FDA Approves Medtronic Attain
Ability Left-Heart Lead For Cardiac Resynchronization Therapy Devices 311
18.4.6 May 04, 2009: BioCardia' s Morph AccessPro Steerable Introducer System
Gains 510(k) Clearance 311
18.4.7 May 04, 2009: Endosense' s Tacticath
Force-Sensing Ablation Catheter Receives CE Mark 312
18.4.8 Apr 28, 2009:
ITGI Medical, Ltd Receives HUD (Humanitarian Use Device) Designation To Over
And Under And Aneugraft Pericardium Covered Stents From FDA 312
18.4.9 Apr
22, 2009: Abiomed Announces US 510(K) Approval For Impella 5.0 312
18.4.10
Apr 09, 2009: US FDA Grants Pre-Market Approval For NMT Medical' s STARFlex
313
18.4.11 Apr 06, 2009: Vasomedical Announces Launch Of BIOX Holter
Monitoring Systems And Analysis Software 313
18.4.12 Mar 31, 2009: Invatec
Receives 510(K) Approval For AMPHIRION DEEP Long Balloon To More Easily Access
And Treat Arteries Below The Knee 314
18.4.13 Mar 30, 2009: Abiomed
Announces FDA Approval For New AB Portable Driver 314
19 Appendix 315
19.1 Global Markets Direct Research Methodology 315
19.2 Coverage 316
19.3 Secondary Research 316
19.4 Primary Research 317
19.5 Models
317
19.6 Forecasts 318
19.7 Expert Panel Validation 318
19.8
Currency Conversion 319
19.9 Contact Us 320
19.10 Disclaimer 320
1.1 List of Tables
Table 1: United States Healthcare
Expenditure, 2003-2010 33
Table 2: Total Number of Doctors in the United
States, 2003-2010 36
Table 3: Number of Doctors by Specialty in the United
States, 2003-2010 37
Table 4: United States Healthcare Trade Statistics,
2001-2006 38
Table 5: Medical Equipment Registration Fee in United States,
2007 45
Table 6: Medical Device Approval Time in United States 45
Table 7: Cardiovascular Devices, Cross Country Comparison, Revenue ($
mn), 2000-2015 50
Table 8: Cardiovascular Devices, United States,
Overall Revenue ($ mn), 2000-2015 51
Table 9: Cardiovascular Devices,
United States, Cross-Category Analysis, 2000-2015 52
Table 10:
Cardiovascular Devices, United States, Overall Revenue ($ mn), Historic,
2000-2008 54
Table 11: Cardiovascular Devices, United States, Overall
Revenue ($ mn), Forecast, 2008-2015 56
Table 12: Cardiovascular
Devices, United States, Category Volume (Units), 2000-2015 57
Table 13:
Cardiovascular Devices, United States, Category Volume (Units), Historic,
2000-2008 57
Table 14: Cardiovascular Devices, United States,
Category Volume (Units), Forecast, 2008-2015 58
Table 15:
Cardiovascular Devices, United States, Company Share by Revenue ($ mn),
2007-2008 59
Table 16: Cardiac Rhythm Management, United States,
Revenue ($ mn) by Segment, Historic, 2000-2008 60
Table 17: Cardiac
Rhythm Management, United States, Revenue ($ mn) by Segment, Forecast,
2008-2015 61
Table 18: Cardiac Resynchronisation Therapy, United
States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 62
Table 19:
Cardiac Resynchronisation Therapy, United States, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 63
Table 20: Implantable
Cardioverter Defibrillator, United States, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 64
Table 21: Implantable Cardioverter
Defibrillator, United States, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 65
Table 22: Pacemaker, United States, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 66
Table 23: Pacemaker, United
States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 67
Table 24:
Cardiac Rhythm Management, United States, Volume (Units) by Segment,
Historic, 2000-2008 68
Table 25: Cardiac Rhythm Management, United
States, Volume (Units) by Segment, Forecast, 2008-2015 69
Table 26:
Cardiac Resynchronisation Therapy, United States, Volume (Units) by
Sub-Segment, Historic, 2000-2008 70
Table 27: Cardiac
Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 71
Table 28: Implantable Cardioverter
Defibrillator, United States, Volume (Units) by Sub-Segment, Historic,
2000-2008 72
Table 29: Implantable Cardioverter Defibrillator, United
States, Volume (Units) by Sub-Segment, Forecast, 2008-2015 73
Table 30:
Pacemaker, United States, Volume (Units) by Sub-Segment, Historic, 2000-2008
74
Table 31: Pacemaker, United States, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 75
Table 32: Cardiac Rhythm Management, United
States, Average Price ($), Historic, 2000-2008 76
Table 33: Cardiac
Rhythm Management, United States, Average Price ($), Forecast, 2008-2015
76
Table 34: Cardiac Rhythm Management, United States, Distribution
Share by Revenue ($mn), 2007-2008 77
Table 35: Cardiac Rhythm
Management, United States, Company Share by Revenue ($ mn), 2007-2008 78
Table 36: Cardiovascular Monitoring and Diagnostic Devices, United
States, Revenue ($ mn) by Segment, Historic, 2000-2008 80
Table 37:
Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($
mn) by Segment, Forecast, 2008-2015 82
Table 38: Cardiovascular
Monitoring and Diagnostic Devices, United States, Volume (Units) by Segment,
Historic, 2000-2008 83
Table 39: Cardiovascular Monitoring and
Diagnostic Devices, United States, Volume (Units) by Segment, Forecast,
2008-2015 84
Table 40: Cardiovascular Monitoring and Diagnostic
Devices, United States, Average Price ($), Historic, 2000-2008 85
Table
41: Cardiovascular Monitoring and Diagnostic Devices, United States,
Average Price ($), Forecast, 2008-2015 85
Table 42: Cardiovascular
Monitoring and Diagnostic Devices, United States, Distribution Share by
Revenue ($mn), 2007-2008 86
Table 43: Cardiovascular Monitoring and
Diagnostic Devices, United States, Company Share by Revenue ($ mn), 2007-2008
87
Table 44: Cardiovascular Prosthetic Devices, United States,
Revenue ($ mn) by Segment, Historic, 2000-2008 88
Table 45:
Cardiovascular Prosthetic Devices, United States, Revenue ($ mn) by Segment,
Forecast, 2008-2015 89
Table 46: Cardiac Assist Devices, United
States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 90
Table 47:
Cardiac Assist Devices, United States, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 91
Table 48: Prosthetic Heart Valve, United
States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 92
Table 49:
Prosthetic Heart Valve, United States, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 93
Table 50: Cardiovascular Prosthetic Devices,
United States, Volume (Units) by Segment, Historic, 2000-2008 94
Table 51:
Cardiovascular Prosthetic Devices, United States, Volume (Units) by
Segment, Forecast, 2008-2015 95
Table 52: Cardiac Assist Devices,
United States, Volume (Units) by Sub-Segment, Historic, 2000-2008 96
Table
53: Cardiac Assist Devices, United States, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 97
Table 54: Prosthetic Heart Valve, United
States, Volume (Units) by Sub-Segment, Historic, 2000-2008 98
Table 55:
Prosthetic Heart Valve, United States, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 99
Table 56: Cardiovascular Prosthetic Devices,
United States, Average Price ($), Historic, 2000-2008 100
Table 57:
Cardiovascular Prosthetic Devices, United States, Average Price ($), Forecast,
2008-2015 100
Table 58: Cardiovascular Prosthetic Devices, United
States, Distribution Share by Revenue ($mn), 2007-2008 101
Table 59:
Cardiovascular Prosthetic Devices, United States, Company Share by Revenue ($
mn), 2007-2008 103
Table 60: Cardiovascular Surgery, United States,
Revenue ($ mn) by Segment, Historic, 2000-2008 105
Table 61:
Cardiovascular Surgery, United States, Revenue ($ mn) by Segment, Forecast,
2008-2015 106
Table 62: Perfusion Disposables, United States, Revenue
($ mn) by Sub-Segment, Historic, 2000-2008 107
Table 63: Perfusion
Disposables, United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
108
Table 64: Cardiovascular Surgery, United States, Volume (Units)
by Segment, Historic, 2000-2008 109
Table 65: Cardiovascular Surgery,
United States, Volume (Units) by Segment, Forecast, 2008-2015 109
Table
66: Perfusion Disposables, United States, Volume (Units) by Sub-Segment,
Historic, 2000-2008 110
Table 67: Perfusion Disposables, United
States, Volume (Units) by Sub-Segment, Forecast, 2008-2015 111
Table 68:
Cardiovascular Surgery, United States, Average Price ($), Historic,
2000-2008 112
Table 69: Cardiovascular Surgery, United States,
Average Price ($), Forecast, 2008-2015 112
Table 70: Cardiovascular
Surgery, United States, Distribution Share by Revenue ($mn), 2007-2008 113
Table 71: Cardiovascular Surgery, United States, Company Share by Revenue
($ mn), 2007-2008 114
Table 72: Electrophysiology, United States,
Revenue ($ mn) by Segment, Historic, 2000-2008 115
Table 73:
Electrophysiology, United States, Revenue ($ mn) by Segment, Forecast,
2008-2015 116
Table 74: Electrophysiology, United States, Volume
(Units) by Segment, Historic, 2000-2008 117
Table 75:
Electrophysiology, United States, Volume (Units) by Segment, Forecast,
2008-2015 117
Table 76: Electrophysiology, United States, Average
Price ($), Historic, 2000-2008 118
Table 77: Electrophysiology,
United States, Average Price ($), Forecast, 2008-2015 118
Table 78:
Electrophysiology, United States, Distribution Share by Revenue ($mn),
2007-2008 119
Table 79: Electrophysiology, United States, Company
Share by Revenue ($ mn), 2007-2008 120
Table 80: Interventional
Cardiology, United States, Revenue ($ mn) by Segment, Historic, 2000-2008
122
Table 81: Interventional Cardiology, United States, Revenue ($
mn) by Segment, Forecast, 2008-2015 124
Table 82: Cardiac Catheter,
United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 125
Table 83: Cardiac Catheter, United States, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 126
Table 84: Coronary Stent, United States,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 127
Table 85:
Coronary Stent, United States, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 128
Table 86: PTCA Balloon, United States, Revenue ($ mn)
by Sub-Segment, Historic, 2000-2008 129
Table 87: PTCA Balloon,
United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 130
Table 88: Interventional Cardiology, United States, Volume (Units) by
Segment, Historic, 2000-2008 132
Table 89: Interventional Cardiology,
United States, Volume (Units) by Segment, Forecast, 2008-2015 134
Table
90: Cardiac Catheter, United States, Volume (Units) by Sub-Segment,
Historic, 2000-2008 135
Table 91: Cardiac Catheter, United States,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 136
Table 92:
Coronary Stent, United States, Volume (Units) by Sub-Segment, Historic,
2000-2008 137
Table 93: Coronary Stent, United States, Volume (Units)
by Sub-Segment, Forecast, 2008-2015 138
Table 94: PTCA Balloon,
United States, Volume (Units) by Sub-Segment, Historic, 2000-2008 139
Table 95: PTCA Balloon, United States, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 140
Table 96: Interventional Cardiology, United
States, Average Price ($), Historic, 2000-2008 141
Table 97:
Interventional Cardiology, United States, Average Price ($), Forecast,
2008-2015 142
Table 98: Interventional Cardiology, United States,
Distribution Share by Revenue ($mn), 2007-2008 143
Table 99:
Interventional Cardiology, United States, Company Share by Revenue ($ mn),
2007-2008 144
Table 100: Peripheral Vascular Devices, United States,
Revenue ($ mn) by Segment, Historic, 2000-2008 146
Table 101:
Peripheral Vascular Devices, United States, Revenue ($ mn) by Segment,
Forecast, 2008-2015 148
Table 102: Peripheral Vascular Devices,
United States, Volume (Units) by Segment, Historic, 2000-2008 150
Table
103: Peripheral Vascular Devices, United States, Volume (Units) by
Segment, Forecast, 2008-2015 152
Table 104: Peripheral Vascular
Devices, United States, Average Price ($), Historic, 2000-2008 153
Table
105: Peripheral Vascular Devices, United States, Average Price ($),
Forecast, 2008-2015 153
Table 106: Peripheral Vascular Devices,
United States, Distribution Share by Revenue ($mn), 2007-2008 154
Table
107: Peripheral Vascular Devices, United States, Company Share by Revenue
($ mn), 2007-2008 155
Table 108: Boston Scientific Corporation
Pipeline Products by Equipment Type 159
Table 109: Boston Scientific
Corporation Pipeline Products By Development Stage 160
Table 110:
Boston Scientific Corporation Pipeline Products By Therapy Area 161
Table
111: Boston Scientific Corporation Pipeline Products By Clinical Trials
162
Table 112: Boston Scientific Corporation Pipeline Products By
News Summaries 163
Table 113: Medtronic, Inc. Pipeline Products by
Equipment Type 167
Table 114: Medtronic, Inc. Pipeline Products By
Development Stage 169
Table 115: Medtronic, Inc. Pipeline Products By
Therapy Area 171
Table 116: Medtronic, Inc. Pipeline Products By
Clinical Trials 173
Table 117: Medtronic, Inc. Pipeline Products By
News Summaries 174
Table 118: Cordis Corporation Pipeline Products by
Equipment Type 175
Table 119: Cordis Corporation Pipeline Products By
Development Stage 175
Table 120: Cordis Corporation Pipeline Products
By Therapy Area 176
Table 121: Cordis Corporation Pipeline Products
By Clinical Trials 176
Table 122: Cordis Corporation Pipeline
Products By News Summaries 177
Table 123: St. Jude Medical Inc.
Pipeline Products by Equipment Type 182
Table 124: St. Jude Medical
Inc. Pipeline Products By Development Stage 182
Table 125: St. Jude
Medical Inc. Pipeline Products By Therapy Area 183
Table 126: St.
Jude Medical Inc. Pipeline Products By Clinical Trials 183
Table 127:
St. Jude Medical Inc. Pipeline Products By News Summaries 184
Table 128:
Abbott Laboratories Pipeline Products by Equipment Type 188
Table 129:
Abbott Laboratories Pipeline Products By Development Stage 188
Table
130: Abbott Laboratories Pipeline Products By Therapy Area 188
Table
131: Abbott Laboratories Pipeline Products By Clinical Trials 189
Table 132: Abbott Laboratories Pipeline Products By News Summaries
189
Table 133: Terumo Corporation Pipeline Products by Equipment Type
192
Table 134: Terumo Corporation Pipeline Products By Development
Stage 192
Table 135: Terumo Corporation Pipeline Products By Therapy
Area 192
Table 136: Terumo Corporation Pipeline Products By Clinical
Trials 193
Table 137: Terumo Corporation Pipeline Products By News
Summaries 193
Table 138: Abbott Vascular Pipeline Products by
Equipment Type 194
Table 139: Abbott Vascular Pipeline Products By
Development Stage 194
Table 140: Abbott Vascular Pipeline Products By
Therapy Area 195
Table 141: Abbott Vascular Pipeline Products By
Clinical Trials 195
Table 142: Abbott Vascular Pipeline Products By
News Summaries 196
Table 143: ABIOMED, Inc. Pipeline Products by
Equipment Type 199
Table 144: ABIOMED, Inc. Pipeline Products By
Development Stage 199
Table 145: ABIOMED, Inc. Pipeline Products By
Therapy Area 200
Table 146: ABIOMED, Inc. Pipeline Products By
Clinical Trials 200
Table 147: ABIOMED, Inc. Pipeline Products By
News Summaries 200
Table 148: AGA Medical Corporation Pipeline
Products by Equipment Type 201
Table 149: AGA Medical Corporation
Pipeline Products By Development Stage 201
Table 150: AGA Medical
Corporation Pipeline Products By Therapy Area 202
Table 151: AGA
Medical Corporation Pipeline Products By Clinical Trials 202
Table 152:
AGA Medical Corporation Pipeline Products By News Summaries 202
Table
153: Angel Medical Systems, Inc. Pipeline Products by Equipment Type
203
Table 154: Angel Medical Systems, Inc. Pipeline Products by
Development Stage 203
Table 155: Angel Medical Systems, Inc. Pipeline
Products By Therapy Area 203
Table 156: Angel Medical Systems, Inc.
Pipeline Products By Clinical Trials 203
Table 157: Angel Medical
Systems, Inc. Pipeline Products By News Summaries 203
Table 158:
Arrow International, Inc. Pipeline Products by Equipment Type 207
Table
159: Arrow International, Inc. Pipeline Products By Development Stage
207
Table 160: Arrow International, Inc. Pipeline Products By Therapy
Area 207
Table 161: Arrow International, Inc. Pipeline Products By
Clinical Trials 207
Table 162: Ash Access Technology, Inc. Pipeline
Products by Equipment Type 208
Table 163: Ash Access Technology, Inc.
Pipeline Products By Development Stage 208
Table 164: Ash Access
Technology, Inc. Pipeline Products By Therapy Area 208
Table 165:
AtriCure, Inc. Pipeline Products by Equipment Type 209
Table 166:
AtriCure, Inc. Pipeline Products By Development Stage 209
Table 167:
AtriCure, Inc. Pipeline Products By Therapy Area 210
Table 168:
AtriCure, Inc. Pipeline Products By Clinical Trials 210
Table 169:
AtriCure, Inc. Pipeline Products By News Summaries 210
Table 170
|
Related Report
|
View Cart
